Future research needs to analyze the following directions: (1) the specific regulatory network of Musclin in different exercise modes (endurance vs. resistance); (2) the mechanism of organ-to-organ communication in its cardioprotection; (3) personalized exercise prescription design based on the dynamic change of Musclin, especially the intervention strategy for patients with metabolic diseases. The gene discussed is OSTN; the disease is Other metabolic disease.